Clinical Trials · NCT01364584
Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University of Colorado, Denver
- Enrollment
- 23
- Start date
- Oct 2010
- Locations
- 1 site, United States
- Primary endpoint
- Peak Oxygen Consumption (VO2 Peak)